Saibene V, Melandri M, Brembilla L, Spotti D, Pozza G
Acta Diabetol Lat. 1981;18(1):45-50. doi: 10.1007/BF02056105.
Circadian blood glucose profiles have been evaluated in 8 insulin-dependent diabetic inpatients on their usual home insulin therapy, on a 3-injection regimen (ultralente in the morning plus 3 injections of regular insulin at meals), on continuous subcutaneous insulin infusion by portable micropumps (Mill Hill 1001) and, again, on a 3-injection regimen at the same insulin dose as during continuous subcutaneous insulin infusion. The 3-injection regimen achieved a mean daily blood glucose level comparable to that obtained by continuous subcutaneous insulin infusion, even if significantly more insulin was needed. At comparable insulin doses, continuous subcutaneous insulin infusion provided a significantly lower mean daily blood glucose. Glycemic control at 0600 and 0800 was better during continuous subcutaneous insulin infusion. Low acceptance by the patients of the home use of portable micropumps was evidenced because of the practical and psychological problems involved.
对8名接受常规家庭胰岛素治疗的胰岛素依赖型糖尿病住院患者进行了昼夜血糖谱评估,治疗方案包括3次注射方案(早晨注射长效胰岛素,三餐时注射常规胰岛素)、使用便携式微型泵(米尔希尔1001)进行持续皮下胰岛素输注,以及再次采用与持续皮下胰岛素输注期间相同胰岛素剂量的3次注射方案。3次注射方案达到的平均每日血糖水平与持续皮下胰岛素输注相当,尽管所需胰岛素明显更多。在胰岛素剂量相当的情况下,持续皮下胰岛素输注的平均每日血糖显著更低。持续皮下胰岛素输注期间,0600和0800时的血糖控制更好。由于存在实际和心理问题,证明患者对在家使用便携式微型泵的接受度较低。